Pneumococcal 20-Valent Conjugate Vaccine（Zhejiang Vacin Biomedicine）

20价肺炎球菌多糖结合疫苗（艾美卫信生物药业）

Report date: 2025/12/29 15:30:20

Base Information

Drug NamePneumococcal 20-Valent Conjugate Vaccine（Zhejiang Vacin Biomedicine）
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Conjugated vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAimei Weixin BioPharm (Zhejiang) Co LtdAimei Explorer Life Science R&D Co LtdAim Vaccine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAimei Explorer Life Science R&D Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A